Categories AlphaGraphs, Consumer, Earnings, Retail

Kroger beats Q2 earnings estimates but revenues fall short

The Kroger Co. (NYSE: KR) topped market estimates for earnings in the second quarter of 2019 but revenue fell short of expectations. Shares were up 3.7% in morning trade on Thursday.

Total sales inched up to $28.2 billion from $28 billion in the same period last year but came in shy of estimates of $28.38 billion. Excluding fuel, dispositions and merger transactions, sales grew 2.5%.

Identical sales, ex fuel, grew 2.2% and digital sales grew 31%.

Kroger beat earnings expectations for Q2 2019 but revenues fell short of estimates

GAAP net income was $297 million, or $0.37 per share, compared to $508 million, or $0.62 per share, in the prior-year quarter. Adjusted EPS totaled $0.44, beating forecasts of $0.41.

The company generated operating profit of $559 million in the quarter. The alternative profit streams are on track to contribute an incremental $100 million in operating profit in 2019 versus 2018.

During the quarter, Our Brands sales rose 3.1% from last year and the company launched 203 new Our Brands items.

Also see: Kroger Q2 2019 Earnings Preview

As part of its Restock Kroger initiatives, Kroger expanded to 1,780 pickup locations and 2,225 delivery locations, covering over 95% of Kroger households. The company also launched Simple Truth Plant Based, a collection of meatless food products to appeal to a new and rapidly-increasing customer base.  

For 2019, Kroger expects GAAP EPS of $2.30-2.40 and adjusted EPS of $2.15-2.25. Identical sales are expected to increase 2% to 2.25%.

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top